Cannabis Terpenes Exhibit Anti-Cancer Effects in Preclinical Trial
Shanghai, China: Hemp oil extracts containing the terpenes β-caryophyllene and α-humulene possess potent analgesic and anti-cancer properties, according to preclinical data published in Fitoterapia: The Journal for the Study of Medicinal Plants.
Chinese scientists assessed the pain-relieving and anti-tumor activities of hemp oil in mice. They reported that the administration of cannabis extracts reduced neuropathic pain and “significantly inhibited” tumor growth.
The study’s authors concluded, “These results reveal that HEO [hemp essential oil] plays a role not only in tumor chemotherapy induced peripheral neuropathy treatment, but also in anti-tumor treatment which offers key information for new strategies in cancer treatment and provides reference for the medicinal development of hemp.”
Prior studies have similarly determined that cannabis terpenes, including β-caryophyllene and α-humulene, can produce potent analgesic effects in animal models. Cannabinoids possess well-established anti-cancer activities in preclinical models, but their efficacy has rarely been assessed in clinical trials.
Cannabis terpenes are produced in the trichomes. Trichomes are the mushroom-shaped, crystal-like resin glands that cover the flowers and leaves of the cannabis plant. Terpenes are volatile and evaporate easily which is why the cannabis plant is so easy to smell.
June 28, 2024
